Results 1 to 10 of about 66,484 (198)

Biomarkers of Cholestasis [PDF]

open access: yesBiomarkers in Medicine, 2021
Cholestasis is a major pathological manifestation, often resulting in detrimental liver conditions, which occurs in a variety of indications collectively termed cholestatic liver diseases. The frequent asymptomatic character and complexity of cholestasis, together with the lack of a straightforward biomarker, hampers early detection and treatment of ...
Pieters, Alanah   +5 more
openaire   +4 more sources

Fibrates and cholestasis [PDF]

open access: yesHepatology, 2015
Cholestasis, including primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC), results from an impairment or disruption of bile production and causes intracellular retention of toxic bile constituents, including bile salts. If left untreated, cholestasis leads to liver fibrosis and cirrhosis, which eventually results in liver failure ...
Nisanne S, Ghonem   +2 more
openaire   +2 more sources

Cholestasis

open access: yesVeterinary Clinics of North America: Small Animal Practice, 1985
Cholestasis can be caused by extrahepatic and intrahepatic pathogenic mechanisms that affect cellular and subcellular functions. The retention of bile results in numerous biochemical abnormalities, some of which are useful as clinical tests. The clinicopathologic findings are often suggestive of the underlying hepatobiliary disorder but are seldom ...
Associate Professor, Department of Medical Sciences, University of Florida College of Veterinary Medicine, Gainesville, FloridaDepartment of Medical SciencesUniversity of Florida College of Veterinary MedicineGainesvilleFlorida ( host institution )   +2 more
openaire   +3 more sources

Cholestasis [PDF]

open access: yesGut, 2003
In contrast with urine formation, bile flow is not dependent on hydrostatic forces, but driven by osmotic pressure of solutes secreted across the apical membrane of hepatocytes and bile duct epithelial cells. This secretory process is mediated by a set of primary active transporters that use ATP hydrolysis to pump solutes against the concentration ...
openaire   +4 more sources

Neonatal Cholestasis [PDF]

open access: yesSeminars in Pediatric Surgery, 2000
In simplest terms, cholestasis is defined as a decrease in bile flow. The clinical manifestations of cholestasis occur because of accumulation of substances normally excreted in the bile; namely bilirubin, bile acids, and cholesterol. Accumulation of bilirubin leads to jaundice and dark urine. Accumulation of bile acids is associated with pruritus, and
F M, Karrer, D D, Bensard
openaire   +4 more sources

Neonatal Cholestasis [PDF]

open access: yesNeoReviews, 2013
Cholestatic jaundice is a common presenting feature of neonatal hepatobiliary and metabolic dysfunction. Any infant who remains jaundiced beyond age 2 to 3 weeks should have the serum bilirubin level fractionated into a conjugated (direct) and unconjugated (indirect) portion. Conjugated hyperbilirubinemia is never physiologic or normal.
Amy G, Feldman, Ronald J, Sokol
openaire   +2 more sources

Cholestasis in Benign Recurrent Intrahepatic Cholestasis 2

open access: yesACG Case Reports Journal, 2020
ABSTRACT Benign recurrent intrahepatic cholestasis represents a rare class of autosomal recessive chronic cholestasis disorders, usually presenting with recurrent episodes of intense pruritus and jaundice. We report a 27-year-old woman presenting with benign recurrent intrahepatic cholestasis type 2 due to ...
Arthur Lorio, Eric   +3 more
openaire   +2 more sources

Genes and cholestasis [PDF]

open access: yesHepatology, 2001
P L, Jansen, M, Müller, E, Sturm
openaire   +2 more sources

Home - About - Disclaimer - Privacy